Responsibility is on the BUYER to select the appropriate shipping option. We are not responsible for any damages that are the result of choosing the wrong shipping option.
Express shipping is recommended for certain items.
ATTENTION! We recommend using Express Shipping for all toxin products.
We will ship your order with an ice pack in a protective thermal bag.
ATTENTION!!! Only Innotox is a Pre-Mix Liquid Toxin. Other Toxins are White to almost clear, vacuum-dried powder in a colorless and transparent vial.
The vial is 100 Units of product, not 100 ml !!!
All Korean Toxins are Heat Resistant and Handle UP TO 100F for 7-10 days (according to manufacturers)
Toxins are NOT returnable or refundable under any circumstances!!!
Expiration date: 09/2024
Please, keep unopened vial should be stored in a freezer (below -5 degree) or refrigerator (2-8 degree)
Innotox is the world’s first liquid injectable form of botulinum Toxin type A approved by KFDA in South Korea, 2013. Allergan, the Botox manufacturer, made an exclusive license agreement to market Innotox worldwide, excluding Korea and Japan. Made by Medytox in Korea.
This product is not temperature sensitive as other brands. Storage them in the refrigerator if you will not use them anytime soon before opening. Once it is open, finish it up within’ a few days it will lose its activation day by days.
Innotox 100U is a South Korean innovative product for smoothing mimic wrinkles on the face. Unlike well-known Botox, it has a liquid pharmaceutical form and an improved formula. It is popular in many countries thanks to the ease of use and long-lasting result.
Innotox 100U is intended for eliminating wrinkles caused by spasticity of muscles or active mimics. It removes lines and folds in the areas of eyes, between the eyebrows, forehead, around the mouth.
- Mimic wrinkles;
- Excessive sweating of palms and armpits (hyperhidrosis)
Injections are made with a 30G needle. Procedure can be carried out only by an experienced cosmetologist.
Description and composition
The product is manufactured by Medytox Inc. in the form of a solution in vials, one in a package. The basic component is botulotoxin type A Clostridium botulinum in the amount of 50 units.
Innotox is predicted by the same Hall strain of C.botulinum as Neuronox and Botox. The molecular weight of Innotox analyzed using size exclusion SE-HPLC is approximately 900 kDa. Which is highly comparable to those of Neuronox and Botox.
Another key characteristic of Innotox is that it excludes the use of substances of animal origin in the manufacturing process to eliminate the risks associated with animal-based proteins. Moreover, it excludes human serum albumin as an excipient of the final product to avoid any risk associated with diseases of human blood origin. Instead it contains methionine and polysorbate as a stabilizer.
The safety and efficacy of Innotox and Botox were compared at a 1:1 dose ratio for treating glabellar lines in a double-blinded, randomized, phase III multi center study with 168 subjects. The patients, aged 20 to 65 years with moderate-to-severe glabellar lines, were randomly treated with 20U of Innotox or Botox and subsequently assessed by blinded investigators. The improvement rate at both maximum frown and rest was not significantly different between the Innotox and Botox groups. No severe adverse drug reactions were observed.
With these advantages, Allergan, the Botox manufacturer, made an exclusive license agreement to market Innotox worldwide, excluding Korea and Japan.
YOU ARE ADVISED TO USE A MEDICAL PROFESSIONAL WHO CAN ADMINISTER THE TREATMENT FOR YOU.